183 related articles for article (PubMed ID: 9448028)
21. Vaccine-derived poliovirus (VDPV): Impact on poliomyelitis eradication.
Minor P
Vaccine; 2009 May; 27(20):2649-52. PubMed ID: 19428874
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity and tolerance following HIV-1/HBV plant-based oral vaccine administration.
Guetard D; Greco R; Cervantes Gonzalez M; Celli S; Kostrzak A; Langlade-Demoyen P; Sala F; Wain-Hobson S; Sala M
Vaccine; 2008 Aug; 26(35):4477-85. PubMed ID: 18601967
[TBL] [Abstract][Full Text] [Related]
23. Sequential immunization of macaques with two differentially attenuated vaccines induced long-term virus-specific immune responses and conferred protection against AIDS caused by heterologous simian human immunodeficiency Virus (SHIV(89.6)P).
Kumar A; Lifson JD; Li Z; Jia F; Mukherjee S; Adany I; Liu Z; Piatak M; Sheffer D; McClure HM; Narayan O
Virology; 2001 Jan; 279(1):241-56. PubMed ID: 11145906
[TBL] [Abstract][Full Text] [Related]
24. Immunogenicity and safety of a combined hepatitis A and B vaccine administered concomitantly with either a measles-mumps-rubella or a diphtheria-tetanus-acellular pertussis-inactivated poliomyelitis vaccine mixed with a Haemophilus influenzae type b conjugate vaccine in infants aged 12-18 months.
Usonis V; Meriste S; Bakasenas V; Lutsar I; Collard F; Stoffel M; Tornieporth N
Vaccine; 2005 Apr; 23(20):2602-6. PubMed ID: 15780442
[TBL] [Abstract][Full Text] [Related]
25. Adult immunizations--a practical approach for clinicians: Part II.
Zimmerman RK; Clover RD
Am Fam Physician; 1995 Apr; 51(5):1139-48, 1151-4. PubMed ID: 7709891
[TBL] [Abstract][Full Text] [Related]
26. Mechanistic actions of the risks and adverse events associated with vaccine administration.
Moylett EH; Hanson IC
J Allergy Clin Immunol; 2004 Nov; 114(5):1010-20; quiz 1021. PubMed ID: 15536401
[TBL] [Abstract][Full Text] [Related]
27. A comparative study of reactogenicity and immunogenicity of an oral and an inactivated polio vaccine.
Borcić B; Dobrovsak-Sourek V; Kaić B; Ljubicić M
Acta Med Croatica; 1998; 52(3):155-8. PubMed ID: 9818437
[TBL] [Abstract][Full Text] [Related]
28. Functionally-inactive and immunogenic Tat, Rev and Nef DNA vaccines derived from sub-Saharan subtype C human immunodeficiency virus type 1 consensus sequences.
Scriba TJ; zur Megede J; Glashoff RH; Treurnicht FK; Barnett SW; van Rensburg EJ
Vaccine; 2005 Jan; 23(9):1158-69. PubMed ID: 15629359
[TBL] [Abstract][Full Text] [Related]
29. [The use of inactivated polio vaccine to prevent polio paralysis associated with the vaccination of children living in orphanages].
Ion-Nedelcu N; Crăciun D; Strebel P; Ciufecu C
Bacteriol Virusol Parazitol Epidemiol; 1997; 42(4):243-8. PubMed ID: 9586335
[No Abstract] [Full Text] [Related]
30. Safety and immunogenicity of a hexavalent diphtheria-tetanus-acellular pertussis-inactivated poliovirus-Haemophilus influenzae b conjugate-hepatitis B vaccine at 2, 3, 4, and 12-14 months of age.
Halperin SA; Tapiero B; Diaz-Mitoma F; Law BJ; Hoffenbach A; Zappacosta PS; Radley D; McCarson BJ; Martin JC; Brackett LE; Boslego JW; Hesley TM; Bhuyan PK; Silber JL
Vaccine; 2009 Apr; 27(19):2540-7. PubMed ID: 19124057
[TBL] [Abstract][Full Text] [Related]
31. [Case of poliomyelitis in unvaccinated children in contact with persons vaccinated with attenuated virus].
Kostrzewski JM
Przegl Epidemiol; 1973; 27(2):259-65. PubMed ID: 4720593
[No Abstract] [Full Text] [Related]
32. [Live attenuated AIDS vaccine possibly lethal].
Ned Tijdschr Geneeskd; 1997 Nov; 141(44):2139. PubMed ID: 9644004
[No Abstract] [Full Text] [Related]
33. [Immunization against HIV. Problems in developing a vaccine].
Uhl D
Med Monatsschr Pharm; 1988 Nov; 11(11):376-8. PubMed ID: 3059163
[No Abstract] [Full Text] [Related]
34. The safety of hepatitis B virus vaccine.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1983 Mar; 32(10):134-6. PubMed ID: 6405154
[No Abstract] [Full Text] [Related]
35. The global impact of vaccination against hepatitis B: a historical overview.
Zanetti AR; Van Damme P; Shouval D
Vaccine; 2008 Nov; 26(49):6266-73. PubMed ID: 18848855
[TBL] [Abstract][Full Text] [Related]
36. Polio vaccine production.
Plotkin SA
Science; 1997 Oct; 278(5335):19. PubMed ID: 9340745
[No Abstract] [Full Text] [Related]
37. Concurrent administration of rhesus rotavirus tetravalent (RRV-TV) vaccine with pentavalent diphtheria-pertussis-tetanus-Haemophilus influenzae beta-inactivated polio and hepatitis B vaccines.
Vesikari T; Joensuu J; Baer M; Käyhty H; Olander RM; Sormunen H; Miettinen A; Ward RL; Guillot T
Acta Paediatr; 1999 May; 88(5):513-20. PubMed ID: 10426173
[TBL] [Abstract][Full Text] [Related]
38. Prime-boost strategies in DNA vaccines.
Dale CJ; Thomson S; De Rose R; Ranasinghe C; Medveczky CJ; Pamungkas J; Boyle DB; Ramshaw IA; Kent SJ
Methods Mol Med; 2006; 127():171-97. PubMed ID: 16988455
[TBL] [Abstract][Full Text] [Related]
39. Conditional virus replication as an approach to a safe live attenuated human immunodeficiency virus vaccine.
Berkhout B; Verhoef K; Marzio G; Klaver B; Vink M; Zhou X; Das AT
J Neurovirol; 2002 Dec; 8 Suppl 2():134-7. PubMed ID: 12491165
[TBL] [Abstract][Full Text] [Related]
40. A novel HBV DNA vaccine based on T cell epitopes and its potential therapeutic effect in HBV transgenic mice.
Li X; Yang X; Jiang Y; Liu J
Int Immunol; 2005 Oct; 17(10):1293-302. PubMed ID: 16113237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
